Canadian News


Myomo Inc. (MYO), a wearable medical robotics company, has signed a nationwide payer agreement with HOMELINK, an expert in orthotic and prosthetic reimbursement.

The Canadian dollar firmed up against its major counterparts in the European session on Wednesday, as the nation's consumer inflation showed a modest increase in January, while a fall in the rate of new coronavirus cases lifted investor sentiment. Data from Statistics Canada showed that inflation...

At 8:30 am ET Wednesday, Canada CPI for January has been published. After the data, the loonie changed little against its major rivals. The loonie was trading at 1.4280 against the euro, 0.8838 against the aussie, 1.3223 against the greenback and 83.68 against the yen around 8:35 am ET.

Canadian shares are likely to open on a positive note on Wednesday, tracking cues from Asian and European markets where stocks edged higher on reports the number of new coronavirus cases dropped for a second consecutive day.

pharma-050517_19feb20.jpg Shares of Rubius Therapeutics Inc. (RUBY) have lost over 57 percent of their value from the yearly high of $20.04, recorded on April 5, 2019, and trade around $8.

The Japanese yen slipped against its major counterparts in the Asian session on Wednesday, as a slowdown in new coronavirus cases in China helped recede the fears over the outbreak. China's National Health Commission said that new infections fell to 1,749 on Tuesday, the lowest since January 29. The...

pharma-010919_19feb20.jpg Today's Daily Dose brings you news about BioCryst Pharma's upcoming regulatory event, Brickell Biotech clearing legal uncertainty related to its lead asset, Bellerophon's phase IIb data of INOPulse, and progress on Lurbinectedin NDA.

The Canadian stock market recovered after a weak start, faltered again, but managed to emerge into positive territory around late afternoon to end the session marginally up on Tuesday.

After a weak start and a subsequent rebound into positive territory, Canadian stocks retreated Tuesday morning, and are currently exhibiting weakness amid cautious moves by investors.

InMode Ltd. (INMD) has reported better-than-expected fourth quarter and full-year 2019 financial results and has provided a rosy outlook for 2020.

Millendo Therapeutics Inc. (MLND), a clinical-stage biopharmaceutical company developing novel treatments for orphan endocrine diseases, has two clinical trial catalysts to watch out for this year.

The Canadian stock market, set to resume trading on Tuesday after an extended weekend, is likely to open on a negative note, due to weakness in global markets after Apple Inc. warned that it is unlikely to meet its sales target due to the virus outbreak.

euro-feb18.jpg The euro fell sharply against its major counterparts in the European session on Tuesday, as German investor sentiment worsened in February to the weakest since November last year, citing worries about the coronavirus outbreak in China. Survey results from the ZEW - Leibniz Centre for European Economic...

scPharmaceuticals Inc. (SCPH), which closed at a new 52-week high of $8.64 in the last trading session of Feb.14, has two late-stage programs with significant market potential.

The commodity currencies such as the Australian, the New Zealand and the Canadian dollars fell against their major counterparts in the Asian session on Tuesday, as risk sentiment faded amid coronavirus concerns and as tech giant Apple warned it does not expect to achieve its revenue forecast for the...

Follow RTT